Concomitant with its ability to mediate T-cell killing of CRC tumor cells, preclinical data show that MGD007 induces expression of PD-1/PD-L1 on T cells and CRC tumor cell lines, respectively. The gene discussed is RPL17; the disease is colorectal carcinoma.